GlaxoSmithKline (France)

Recent papers from GlaxoSmithKline (France)

1. In vitro characterization of GSK2556286 in combination with bedaquiline and pretomanid against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy · 2026
2. The Human Chk1 Inhibitor CHIR-124 Shows Multistage Activity against the Human Malaria Parasite Plasmodium falciparum via Polypharmacological Inhibition of Pf Ark1 and Hemozoin FormationACS Chemical Biology · 2026
3. The pyrrolidinamide antimalarial drug MMV367 rapidly clears blood-stage Plasmodium falciparum in healthy adults with experimental malariaScience Translational Medicine · 2026
4. Enhancing agility and international performance through learning processes and digitalization capabilities in Nigerian SMEsJournal of Business Research · 2026
5. Management of adverse events in TB care and active TB drug safety monitoringBreathe · 2026
6. Query Matters: How Selection Strategies Influence Active Learning in Drug DiscoveryJournal of Chemical Information and Modeling · 2026
7. Preparing for Tuberculosis Vaccine M72/AS01E Implementation: A Global Demand Forecast and Key Influential FactorsInfectious Diseases and Therapy · 2026
8. ELISA method to assign weight-based antibody concentration to antigen-specific Ig in seraJournal of Immunological Methods · 2026
9. Immunogenicity evaluation of altSonflex1-2–3 Shigella vaccine across mice, rats, and rabbits to inform human translational insightsFrontiers in Immunology · 2026
10. Diaryl-Aminoindazole with Extensive In Vitro Mycobactericidal Activity Dependent on Exposure to Reactive Nitrogen SpeciesACS Infectious Diseases · 2026
11. How to differentiate between clinical added value (CAV) V drugs: What are the implications, and what is the access pathway?Therapies · 2025
12. Comment discriminer les médicaments d’ASMR V : quelles implications et quel parcours d’accès ?Therapies · 2025
13. Structural, Microstructural, and Magnetic Properties of Ce and Sr- co -Substituted (La 2– x Vac x )NiTiO ₆ ( x = 0, 0.1) PerovskitesThe Journal of Physical Chemistry C · 2025
14. Fragment-Based Development of Small Molecule Inhibitors Targeting Mycobacterium tuberculosis Cholesterol MetabolismJournal of Medicinal Chemistry · 2025
15. The characterization of Klebsiella pneumoniae associated with neonatal sepsis in low- and middle-income countries to inform vaccine designCommunications Biology · 2025
16. The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or DeathThe Journal of Infectious Diseases · 2025
17. High-throughput screening of small molecules targeting Mycobacterium tuberculosis in human iPSC macrophagesAntimicrobial Agents and Chemotherapy · 2025
18. The critical role of PSAC channel in malaria parasite survival is driven home by phenotypic screening under relevant nutrient levelsCell chemical biology · 2025
19. A three-dimensional high throughput assay identifies novel antibacterial molecules with activity against intracellular Shigellanpj Antimicrobials and Resistance · 2025
20. Leishmania sand fly-transmission is disrupted by Delftia tsuruhatensis TC1 bacteriaNature Communications · 2025